Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hider

Showing results (151-160 of 348) with videos related to

Pageof 35
Sort By:
The Journal of Pharmacy and Pharmacology|July 20, 1999
Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potentialZ D Liu, D Y Liu, S L Lu, et al.
Pharmacology & Toxicology|June 22, 2000
Hydrolytic and metabolic characteristics of the esters of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41), potentially useful iron chelatorsD Y Liu, Z D Liu, S L Lu, et al.
Dalton Transactions (Cambridge, England : 2003)|November 20, 2019
Synthesis and iron coordination properties of schizokinen and its imide derivativeHataichanok Chuljerm, Yu-Lin Chen, Somdet Srichairatanakool, et al.
Analytical Biochemistry|May 15, 1992
Quantification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and simultaneous ultraviolet-visible/radioactive detectionS Singh, N Mohammed, R Ackerman, et al.
The Journal of Physical Chemistry Letters|August 21, 2015
Prediction of Absolute Hydroxyl pKa Values for 3-Hydroxypyridin-4-onesYu-Lin Chen, Nikos L Doltsinis, Robert C Hider, et al.
FEBS Letters|March 3, 1986
The conformation of apaminC M Freeman, C R Catlow, A M Hemmings, et al.
Molecular Pharmacology|May 1, 1983
Ionization processes of some harmala alkaloidsK T Douglas, R K Sharma, J F Walmsley, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|May 15, 1993
3-[1-(Ethylamino)ethylidene]-6-methyl-3H-pyran-2,4-dioneG Xiao, D Van Der Helm, R C Hider, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 15, 2010
Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferipronePatricia Evans, Reem Kayyali, Robert C Hider, et al.
The Biochemical Journal|October 9, 2007
Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapyLakshmi D Devanur, Robert W Evans, Patricia J Evans, et al.
Pageof 35

Showing results (151-160 of 348) with videos related to

Sort By:
Pageof 35
The Journal of Pharmacy and Pharmacology|July 20, 1999
Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potentialZ D Liu, D Y Liu, S L Lu, et al.
Pharmacology & Toxicology|June 22, 2000
Hydrolytic and metabolic characteristics of the esters of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41), potentially useful iron chelatorsD Y Liu, Z D Liu, S L Lu, et al.
Dalton Transactions (Cambridge, England : 2003)|November 20, 2019
Synthesis and iron coordination properties of schizokinen and its imide derivativeHataichanok Chuljerm, Yu-Lin Chen, Somdet Srichairatanakool, et al.
Analytical Biochemistry|May 15, 1992
Quantification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and simultaneous ultraviolet-visible/radioactive detectionS Singh, N Mohammed, R Ackerman, et al.
The Journal of Physical Chemistry Letters|August 21, 2015
Prediction of Absolute Hydroxyl pKa Values for 3-Hydroxypyridin-4-onesYu-Lin Chen, Nikos L Doltsinis, Robert C Hider, et al.
FEBS Letters|March 3, 1986
The conformation of apaminC M Freeman, C R Catlow, A M Hemmings, et al.
Molecular Pharmacology|May 1, 1983
Ionization processes of some harmala alkaloidsK T Douglas, R K Sharma, J F Walmsley, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|May 15, 1993
3-[1-(Ethylamino)ethylidene]-6-methyl-3H-pyran-2,4-dioneG Xiao, D Van Der Helm, R C Hider, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 15, 2010
Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferipronePatricia Evans, Reem Kayyali, Robert C Hider, et al.
The Biochemical Journal|October 9, 2007
Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapyLakshmi D Devanur, Robert W Evans, Patricia J Evans, et al.
Pageof 35